Subcortical structures in amyotrophic lateral sclerosis
Publication date
2015-02-01
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
The aim of this study was to assess the involvement of deep gray matter, hippocampal subfields, and ventricular changes in patients with amyotrophic lateral sclerosis (ALS). A total of 112 ALS patients and 60 healthy subjects participated. High-resolution T1-weighted images were acquired using a 3T MRI scanner. Thirty-nine patients underwent a follow-up scan. Volumetric and shape analyses of subcortical structures were performed, measures were correlated with clinical parameters, and longitudinal changes were assessed. At baseline, reduced hippocampal volumes (left: p= 0.007; right: p= 0.011) and larger inferior lateral ventricles (left: p= 0.013; right: p= 0.041) were found in patients compared to healthy controls. Longitudinal analyses demonstrated a significant decrease in volume of the right cornu ammonis 2/3 and 4/dentate gyrus and left presubiculum (. p= 0.002, p= 0.045, p < 0.001), and a significant increase in the ventricular volume in the lateral (left: p < 0.001; right: p < 0.001), 3rd (. p < 0.001) and 4th (. p= 0.001) ventricles. Larger ventricles were associated with a lower ALSFRS-R score (. p= 0.021). In conclusion, ALS patients show signs of neurodegeneration of subcortical structures and ventricular enlargement. Subcortical involvement is progressive and correlates with clinical parameters, highlighting its role in the neurodegenerative process in ALS.
Keywords
Amyotrophic lateral sclerosis, Basal ganglia, Hippocampal subfields, Longitudinal, Magnetic resonance imaging, Taverne, Clinical Neurology, General Neuroscience, Ageing, Developmental Biology, Geriatrics and Gerontology
Citation
Westeneng, H J, Verstraete, E, Walhout, R, Schmidt, R, Hendrikse, J, Veldink, J H, van den Heuvel, M P & van den Berg, L H 2015, 'Subcortical structures in amyotrophic lateral sclerosis', Neurobiology of Aging, vol. 36, no. 2, pp. 1075-1082. https://doi.org/10.1016/j.neurobiolaging.2014.09.002